Posts found in:

Michael Wysolmerski

KO Pharmacology Research and Drug Discovery Client Plato BioPharma, Inc. Acquired by Inotiv, Inc. Image

KO Pharmacology Research and Drug Discovery Client Plato BioPharma, Inc. Acquired by Inotiv, Inc.

KO Client Plato BioPharma, Inc., a Colorado-based pharmacology research and drug discovery company, has been acquired by leading contract research organization Inotiv, Inc. The KO team, led by partner John Gaddis, represented Plato BioPharma in the acquisition. Plato BioPharma specializes in cardiovascular, renal, pulmonary and hepatic therapeutic areas, specifically within…

KO Client Sydnexis Completes $45M Series B Financing Image

KO Client Sydnexis Completes $45M Series B Financing

Sydnexis, Inc., a clinical stage biopharmaceutical company, has completed a $45 million Series B financing led by Visionary Ventures, Blue Stem Capital, and SC Master Fund. The KO team, led by partners Kevin Gibson and Brad Schoenfeld, represented Sydnexis. The company sees progressive myopia (nearsightedness) in children as a ‚Äúsignificant…